Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)

Name: Phase I Trial of a Recombinant SARS-CoV-2 Vaccine (Sf9 Cell)
License: Public Domain

Jiangsu Province Centers for Disease Control and Prevention

ClinicalTrials.gov · Datasets · License: Public Domain

covid-19

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 174974
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.